AIM
SPHS

Acrospire Investment Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Acrospire Investment Management’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,034
Closed -$9K – 2105
2017
Q2 		$9K Sell
4,034
-1,700
-30% -$4.16K 0.01% 1846
2017
Q1 		$16K Sell
5,734
-15,367
-73% -$42.1K 0.01% 1724
2016
Q4 		$59K Buy
21,101
+400
+2% +$1.13K 0.02% 1294
2016
Q3 		$64K Buy
20,701
+5,990
+41% +$22.5K 0.04% 890
2016
Q2 		$32K Buy
14,711
+5,059
+52% +$6.99K 0.02% 1361
2016
Q1 		$14K Buy
+9,652
New +$17K 0.01% 1673

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Acrospire Investment Management's SPHS Position: Q3 2017 in Review

Acrospire Investment Management sold out of Sophiris Bio, Inc. (SPHS) in Q3 2017, closing a stake of 4,034 shares — an estimated $9K sold.

Acrospire Investment Management first reported a position in SPHS in Q1 2016 and held it in 6 quarters. The position peaked at $64K in Q3 2016. 25 funds tracked by Wall St. Rank hold SPHS as of Q3 2017.

  • Acrospire Investment Management reported no remaining Sophiris Bio, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 4,034 Sophiris Bio, Inc. shares in Q3 2017, an estimated $9K.
  • Acrospire Investment Management first reported a position in Sophiris Bio, Inc. in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Sophiris Bio, Inc. position peaked at $64K in Q3 2016.
  • 25 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.